Search Results - David F. Stroncek
- Showing 1 - 11 results of 11
-
1
-
2
-
3
-
4
Identification of genomic determinants contributing to cytokine release in immunotherapies and human diseases by Lipei Shao, Alejandra Pelayo, Rongye Shi, Jinxia Ma, Hui Liu, Yihua Cai, Michaela Prochazkova, Robert P. Somerville, Sandhya R. Panch, Nirali N. Shah, David F. Stroncek, Ping Jin
Published in Journal of Translational Medicine (2022-07-01)Get full text
Article -
5
Robust Selections of Various Hematopoietic Cell Fractions on the CliniMACS Plus Instrument by Sandhya R. Panch, Opal L. Reddy, Katherine Li, Thejaswi Bikkani, Anusha Rao, Swathi Yarlagadda, Steven Highfill, Daniel Fowler, Richard W. Childs, Minocher Battiwalla, John Barrett, Andre Larochelle, Crystal Mackall, Nirali Shah, David F. Stroncek
Published in Clinical Hematology International (2019-09-01)Get full text
Article -
6
Systematic evaluation of immune regulation and modulation by Francesco Marincola, David F Stroncek, Barbara Seliger, Lisa H. Butterfield, David R. Kaufman, Firouzeh Korangy, Sergio Rutella, Peter P. Lee, Madhav V. Dhodapkar, Michael A. Cannarile, Tim F. Greten, Jean Charles Grivel, Heidi H. Kong, Janet C. Siebert, Giorgio Trinchieri
Published in Journal for ImmunoTherapy of Cancer (2017-08-01)Get full text
Article -
7
Tbet and IL-36γ cooperate in therapeutic DC-mediated promotion of ectopic lymphoid organogenesis in the tumor microenvironment by Aliyah M. Weinstein, Lu Chen, Emily A. Brzana, Prashanti R. Patil, Jennifer L. Taylor, Kellsye L. Fabian, Callen T. Wallace, Sabrina D. Jones, Simon C. Watkins, Binfeng Lu, David F. Stroncek, Timothy L. Denning, Yang-Xin Fu, Peter A. Cohen, Walter J. Storkus
Published in OncoImmunology (2017-06-01)Get full text
Article -
8
Regression of renal cell carcinoma by T cell receptor-engineered T cells targeting a human endogenous retrovirus by Long Chen, David F Stroncek, Gang Zeng, Steven Highfill, Robert Reger, Stefan Barisic, Elena Cherkasova, Elizabeth M Brahmbhatt, Timothy T Spear, Ujjawal Savani, Stephanie Pierre, Gina M Scurti, Muna Igboko, Rosa Nadal, Gordon Parry, Annika V Dalheim, Michael I Nishimura, Richard W Childs
Published in Journal for ImmunoTherapy of Cancer (2024-09-01)Get full text
Article -
9
Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and γδ T cell output by Hannah W. Song, Mehdi Benzaoui, Alka Dwivedi, Sarah Underwood, Lipei Shao, Sooraj Achar, Vesna Posarac, Victoria A. Remley, Michaela Prochazkova, Yihua Cai, Ping Jin, Robert P. Somerville, David F. Stroncek, Grégoire Altan-Bonnet, Nirali N. Shah, Christopher D. Chien, Naomi Taylor, Steven L. Highfill
Published in Molecular Therapy: Methods & Clinical Development (2024-03-01)Get full text
Article -
10
Deciphering the importance of culture pH on CD22 CAR T-cells characteristics by Michaela Prochazkova, Alexandra Dreyzin, Lipei Shao, Pam Garces, Yihua Cai, Rongye Shi, Alejandra Pelayo, Yong Soo Kim, Victoria Pham, Sue Ellen Frodigh, Shannon Fenton, Catherine Karangwa, Yan Su, Kathryn Martin, Nan Zhang, Steven L. Highfill, Robert P. Somerville, Nirali N. Shah, David F. Stroncek, Ping Jin
Published in Journal of Translational Medicine (2024-04-01)Get full text
Article -
11
Immunotherapy biomarkers 2016: overcoming the barriers by Jeffrey Schlom, Lisa H Butterfield, Jianda Yuan, Alessandra Cesano, Janet Siebert, Barbara Seliger, Jay A. Berzofsky, James L. Gulley, Holden Maecker, Bernard A. Fox, Marcus O. Butler, Cristina Maccalli, Sacha Gnjatic, Vaios Karanikas, Ilan Kirsch, Sylvia Janetzki, Samir N. Khleif, Magdalena Thurin, Peter P. Lee, Shyam Kalavar, David F. Stroncek
Published in Journal for ImmunoTherapy of Cancer (2017-08-01)Get full text
Article
